UBS’s PHARMACYCLICS INC PCYC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$3.6M Buy
30,700
+28,100
+1,081% +$3.2M ﹤0.01% 2343
2014
Q2
$233K Buy
2,600
+2,000
+333% +$188K ﹤0.01% 4996
2014
Q1
$60K Sell
600
-9,400
-94% -$1.22M ﹤0.01% 6612
2013
Q4
$1.06M Buy
10,000
+200
+2% +$24.3K ﹤0.01% 3483
2013
Q3
$1.35M Buy
9,800
+6,600
+206% +$732K ﹤0.01% 3004
2013
Q2
$254K Buy
+3,200
New +$261K ﹤0.01% 4847

Other funds holding PCYC

UBS's PCYC Position: Q3 2014 in Review

UBS increased its PHARMACYCLICS INC (PCYC) stake by 87% in Q3 2014, buying an estimated $4.54M and bringing the position to 85,596 shares worth $10.1M. The position accounts for 0.01% of the portfolio, ranked #1446.

UBS first reported a position in PCYC in Q2 2013 and has held it in 6 quarters since. The position peaked at $16.1M in Q3 2013. 250 funds tracked by Wall St. Rank hold PCYC as of Q3 2014.

  • UBS held 85,596 shares of PHARMACYCLICS INC worth $10.1M as of Q3 2014.
  • UBS bought 39,858 PHARMACYCLICS INC shares in Q3 2014, an estimated $4.54M.
  • PHARMACYCLICS INC made up 0.01% of UBS's portfolio in Q3 2014, its #1446 holding.
  • UBS first reported a position in PHARMACYCLICS INC in Q2 2013 and has held it in 6 quarters since.
  • UBS's PHARMACYCLICS INC position peaked at $16.1M in Q3 2013.
  • 250 funds tracked by Wall St. Rank held PHARMACYCLICS INC as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.